EU Awards Biovista $500,000 for Personalized Medicine Project | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biovista today announced its European Union affiliate has been awarded a $500,000 grant to apply its technology to an EU project in personalized medicine.

The grant will be used by the firm to apply the multi-dimensional profiling capabilities of its Clinical Outcomes Search Space platform to identify new treatments "that reflect patients' individual pathophysiological characteristics," it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.